The false promise of cellular tests for Lyme borreliosis
- PMID: 35714661
- DOI: 10.1016/S1473-3099(22)00230-4
The false promise of cellular tests for Lyme borreliosis
Conflict of interest statement
EST participates on an advisory board for Serimmun and Euroimmun US. BSP serves on the Board of Governors for the College of American Pathologists and has received support to attend CAP meetings.
Comment on
-
Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.Lancet Infect Dis. 2022 Sep;22(9):1388-1396. doi: 10.1016/S1473-3099(22)00205-5. Epub 2022 Jun 14. Lancet Infect Dis. 2022. PMID: 35714662
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
